Inactive Instrument

SINCLAIR IS PHARMA Share Price Euronext Paris

Equities

End-of-day quote Euronext Paris Other stock markets
- ^EUR	-

2018	European shares bounce as trade deal hopes lift risk appetite	RE
2018	Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28)	RE

European shares bounce as trade deal hopes lift risk appetite	29/18/29	RE
Huadong Medicine : Sinclair Pharma agrees to potential offer from China's Huadong (Aug 28)	29/18/29	RE
Huadong Medicine : Sinclair Pharma says Chinese firms given more time to make takeover offer	16/18/16	RE
Huadong Medicine : Britain's Sinclair Pharma gets takeover interest from Chinese firms, shares soar	05/18/05	RE
Sinclair Pharma : first-half sales up 16 percent, sees momentum continuing	19/17/19	RE
Alliance Pharma : first-half revenue rises on strong sales abroad	13/17/13	RE
Sinclair IS Pharma : says evaluating options including sale	25/14/25	RE
Sinclair IS Pharma : full-year revenue jumps as acquisitions pay off	18/14/18	RE

Sinclair Pharma : Interim Results 2018	27/18/27	PU
Sinclair Pharma : announces $5 million investment by EW Healthcare Partners via convertible loan	22/18/22	PU
Sinclair Pharma : and ThermiGen terminate US distribution agreement	22/18/22	PU
Sinclair Pharma : Aesthetic surgery journal confirms efficacy and consumer acceptance of absorbable suture suspension	29/18/29	PU
Sinclair Pharma : Director/PDMR Shareholding	17/18/17	PU

Sinclair IS Pharma : va quitter la cote parisienne.	27/13/27
Sinclair IS Pharma PLC : Trading update	13/12/13
Sinclair IS Pharma PLC : Invida launches announcement FR	22/11/22
SINCLAIR PHARMA ORD 1P : Accord de licence avec Teva pour episil	31/11/31
SINCLAIR PHARMA ORD 1P : Accord d’option de licence pour le delmopinol	04/11/04

Managers	Title	Age	Since
Miguel Pardos CEO	Chief Executive Officer	-	01/22/01
Santiago Calavia PRN	Corporate Officer/Principal	-	-
Julie Moreau PRN	Corporate Officer/Principal	-	-

Members of the board	Title	Age	Since
Cheng Wei Liu CHM	Chairman	50	-
Miguel Pardos CEO	Chief Executive Officer	-	01/22/01
Gen Li BRD	Director/Board Member	-	27/23/27

Sector

	1st Jan change	Capi.
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.81%	43.34B
OTSUKA HOLDINGS CO., LTD.	+20.44%	21.96B
SANDOZ GROUP AG	+13.30%	14.09B
CIPLA LIMITED	+12.97%	13.64B
ZYDUS LIFESCIENCES LIMITED	+39.74%	11.43B
ONO PHARMACEUTICAL CO., LTD.	-8.59%	6.86B
THE MEDICINES COMPANY	-0.05%	6.79B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+8.46%	5.22B